Polyvinyl alcohol microspheres, injectable solutions and therapeutic uses of the same

Patent Citations (77)

Non-Patent Literature (87)

• Barnes et al, Cytometry, 1999, vol. 36, No. 3, pp. 169-175.Examiner
• Bachtsi et al, Journal of Microencapsulation, 1995, vol. 12, No. 1, pp. 23-35.Examiner
• Hawley's 12th Edition, 1993, Condensed Chemical Dictionary by Richard J. Lewis, Sr., pp. 1058-1059.Examiner
• U.S. Appl. No. 12/534,070, filed Jul. 31, 2009, Vogel et al.Applicant
• Bachtsi & Kiparissides, “An Experimental Investigation of Enzyme Release from Poly(vinyl alcohol) Crosslinked Mircospheres,” J Microencapsulation 12(1):23-35 (1995).Applicant
• Barnes et al., “Fluorescence imaging of single molecules in polymer microspheres,” Cytometry 36:169-175 (1999).Applicant
• Barton et al., “Embolization of bone metastases,” J. Vasc. Interv, Radiol. 7:81-88 (1996).Applicant
• Brown et al., “Synthese et copolymerisation de nouveaux monomeres acryliques diiodes et triodes,” Bulletin de la Societe Chimique de France, No. 4. 839-847 (1986).Applicant
• Boschetti, “Polyacrylamide Derivatives to the Service of Bioseparations,” J. Biochem. Biophys. Meth. 19:21-36 (1989).Applicant
• Dunn, “The peculiarities of polyvinyl alcohol,” Chemistry & Industry, London, pp. 801-806 (1980).Applicant
• Finch, “Properties and Applications,” Polyvinyl Alcohol, p. 640, Wiley, New York (1973).Applicant
• Flandroy et al., “Clinical Applications of Microspheres in Embolization and Chemoembolization: A Comprehensive Review and Perspectives,” In: Pharmaceutical Particulate Carriers in Medical Applications, (Rolland, A., Ed., New York: Marcel Dekker, Inc.) 61: 321-366 (1993).Applicant
• Hori et al., “A New Embolic Material: Superabsorbant Polymer Microspehre and Its Embolic Effectes.” J International Radio 11(3): 75-81 (1996) [English Translation; English translated Title: “Study on the Effect of Arterial Embolization with Super-absorbent Polymer”].Applicant
• Hori et al., “A New Embolic Material: Superabsorbant Polymer Microspehre and Its Embolic Effectes.” J International Radiol 11(3): 75-81 (1996) [Japanese].Applicant
• Hori et al., “A study of development and practical uses of new arterial embolic materials (Super Water-absorbent Resins,” Innervision 13:24 (1998).Applicant
• Hori et al., “An Experimental Study of a New Embolic Material-Lipiodol Suspension of Water-Absorbent Particle,” Nippon Acta Radiologica 53(1):50-56 (1993).Applicant
• Hori et al., “Embolotherapy of Large Hepatocellular Carcinoma Using a New, Permanent, Spherical Embolic Material Without Anti-Neoplastic Agents,” Cardiovasc Intervent Radiol 24 (Suppl 1) S203 (2001).Applicant
• Hori et al., “Vessel Embolic Materials,” Intervent Radiol 33:109-112 (1999).Applicant
• Hori et al. “Study on the effect of arterial embolization with super-absorbant polymer” Intervent. Radiol. 11:1-11 (1996) (Japanese).Applicant
• Hori et al. “Study on the effect of arterial embolization with super-absorbant polymer” Intervent. Radiol. 11:1-11 (1996) (English Translation).Applicant
• Inoue et al., “Experimental Studies of Segmental Hepatic Artery Embolization with a Super Absorbent Embolic Agent,” Nippon Acta Radiologica 50:1439-1441 (1990).Applicant
• Iwase et al., “Hand-Assisted Laparoscopic Splenectomy for Idiopathic Thrombocytopenic Purpura During Pregnancy,” Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 11(1):53-56 (2001).Applicant
• Iwase et al., “Laparoscopically Assisted Splenectomy following Preoperative Splenic Artery Embolization Using Contour Emboli for Myelofibrosis with Massive Splenomegaly,” Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 9(3):197-202 (1999).Applicant
• Iwase et al., “Splenic Artery Embolization Using Contour Emboli before Laparoscopic or Laparoscopically Assisted Splenectomy,” Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 12(5):331-336 (2002).Applicant
• Jiaqi, “A New Embolic Material: Super Absorbent Polymer (SAP) Microsphere and its Embolic Effects,” Nippon Acta Radiologica 56(1):19-24 (1996) (Japanese).Applicant
• Jiaqi, “A New Embolic Material: Super Absorbent Polymer (SAP) Microsphere and its Embolic Effects,” Nippon Acta Radiologica 56(1):19-24 (1996) (English Translation).Applicant
• Khankan et al., “Embolic Effects of Superabsorbent Polymer Microspheres in Rabbit Renal Model: Comparison with Trisacryl Gelatin Microspheres and Polyvinyl Alcohol,” Radiat Med 22(6):384-390 (2004).Applicant
• Kimura et al., “Transcatherterial Embolization of AVM in Pancreas,” Japanese J Clin Radiol 43:311-314 (1998).Applicant
• Kitamura et al., “Polymer with a High Water Absorption Property—Sumika Gel,” Sumitomo Chemical Special Issue. 1-9 (1980) (Japanese).Applicant
• Kitamura et al., “Polymer with a High Water Absorption Property—Sumika Gel,” Sumitomo Chemical Special Issue 1-9 (1980) (English translation).Applicant
• Kusano et al., “Low-Dose Particulate Polyvinylalcohol Embolization in Massive Small Artery Intestinal Hemorrhage. Experimental and Clinical Results,” Investigative Radiology 22:388-292 (1987).Applicant
• Lewis, “Hawley's Condensed Chemical Dictionary,” 12th Edition, pp. 1058-1059 (1993).Applicant
• Marvel et al., “End Group Structure of Polyvinyl Alcohol,” The Journal of the American Chemical Society 65: 1710 (1943).Applicant
• Marvel et al., “The Structure of Vinyl Polymers. II. Polyvinyl Alcohol,” The Journal of the American Chemical Society 60:1045 (1938).Applicant
• Mavligit et al., “Gastrointestinal Leiomyosarcoma Metastatic to the Liver,” Cancer 75(8):2083-2088, (1995).Applicant
• Merck Index, “Polysorbates,” 12th Ed., Merck & Col., Inc., p. 1308 (1996).Applicant
• Motohashi et al., “Superabsorbant Sumikagel®,” Sumitomo Chemistry 35-47 (1985) [Japanese].Applicant
• Motohashi et al, “Superabsorbant Sumikagelt®,” Sumitomo Chemistry 35-47 (1985) [English translation].Applicant
• Müller-Schulte & Brunner, “Novel Magnetic Microspheres on the Basis of Poly(vinyl alcohol) as Affinity Medium for Quantitative Detection of Glycated Haemoglobin,” J. Chromatography A 711:53-60 (1995).Applicant
• Norrby et al., “Angiogenesis: new aspects relating to its initiation and control,” APMIS 105:417-437 (1997).Applicant
• Leeds, “Vinyl Polymers (Alcohol),” Encyclopedia of Chemical Technology, Kirkothmer ed., 21 :353-368, Wiley-Interscience, New York, 2nd ed., (1970).Applicant
• McDowell, et al., “Some Relationships between Polyvinyl Acetates and Polyvinyl Alcohols,” J. Am. Soc. 62:415 (1940).Applicant
• Osuga et al., “Management of Advanced Pelvic Bone Tumors by Transarterial Embolotherapy Using SAP-Microspheres. A Preliminary Report,” Cardiovasc Intervent Radio1 22:S130 (1999).Applicant
• Osuga et al., “Embolization of High Flow Arteriovenous Malformations: Experience with Use of Superabsorbent Polymer Microspheres,” J Vase Intervent Radiol 13(11):1125-1133 (2002).Applicant
• Osuga et al., “A New Embolic Material: SAP-Microsphere,” Japanese Journal of Clinical Medicine 59 Suppl 6:534-538 (2001).Applicant
• Osuga et al., “Transarterial Embolization for Large Hepatocellular Carcinoma with Use of Superabsorbent Polymer Microspheres: Initial Experience,” J Vasc Intervvent Radiol 13(9 Pt 1)929-934 (2002).Applicant
• Repa et al., “Mortalities Associated with Use of a Commercial Suspension of Polyvinyl Alcohol,” Radiology 170(2):395-399 (1989).Applicant
• Rump et al., “Pharmacokinetics of intraarterial mitomycin C in the chemoembolisation treatment of liver metastases,” Gen. Pharmac. 27(4): 669-671 (1996).Applicant
• Thanoo et al., “Controlled release of oral drugs from cross-linked polyvinyl alcohol microspheres,” J Pharm. Pharmacol. 45:16-20 (1993).Applicant
• O'Reilly, “The preclinical evaluation of angiogenesis inhibitors,” Investigational New Drugs 15:5-13(1997).Applicant
• Tao et al., “Study on Microspheres for Embolization of Hepatic Artery,” Acta Pharmaceutica Sinica 23(1):55-60 (1988) [Chinese].Applicant
• Tao et al., “Study on Microspheres for Embolization of Hepatic Artery,” Acta Pharmaceutica Sinica 23(1):55-60 (1988) [English Translation].Applicant
• Thanoo et al., “Preparation and Properties of Barium Sulphate and Methyl Lothalamate Loaded Poly(vinyl Alcohol) Microspheres as Radiopaque Particulate Emboli,” J. Applied Biomaterials 2:67-72 (1991).Applicant
• Wakhloo et al., “Extended Preoperative Polyvinyl Alcohol Microembolization of Intracranial Meningiomas: Assessment of Two Embolization Techniques,” American Journal of Neurology 14:571-582 (1993).Applicant
• Ziegler et al., “Angiogenesis Research Enjoys Growth Spurt in the 1990s,” Journal of the National Cancer Institute 88(12):786-788 (1996).Applicant
• Zou et al., “Experimental Canine Hepatic Artery Embolization With Polyvinyl Alcohol Microsphere,” Zhonghua Fang She Xue Za Zhi (Chin. J. Radiol.) 23(6):330-332 (1989) [Chinese].Applicant
• Zou et al., “Experimental Canine Hepatic Artery Embolization With Polyvinyl Alcohol Microsphere,” Zhonghua Fang She Xue Za Zhi (Chin. J. Radio.) 23(6):330-332 (1989) [English Translation].Applicant
• Derdeyn et al.., “Polyvinyl Alcohol Particle Size and Suspension Characteristics,” AJNR Am. J. Neuroradiol. 16(6):1335-1343 (1995).Applicant
• Opposition of EP1128816B1—Notice of Opposition dated Dec. 22, 2004.Applicant
• Opposition of EP1128816B1—Patentee Reply dated Aug. 10, 2005.Applicant
• Opposition of EP1128816B1—Opponent Reply dated Feb. 21, 2006.Applicant
• Opposition of EP1128816B1—Patentee Reply dated Mar. 8, 2007.Applicant
• Opposition of EP1128816B1—Opponent Supplemental Reply dated May 2, 2007.Applicant
• Opposition of EP1128816B1—EPO Summons to Attend Oral Proceedings and Preliminary Opinion dated May 14, 2007.Applicant
• Opposition of EP1128816B1—Patentee Reply dated Oct. 10, 2007.Applicant
• Opposition of EP1128816B1—Opponent Reply dated Oct. 10, 2007.Applicant
• Opposition of EP1128816B1—Patentee Reply dated Dec. 3, 2007.Applicant
• Opposition of EP1128816B1—Minutes of Oral Proceedings held Dec. 10, 2007; dated Dec. 27, 2007.Applicant
• Opposition of EP1128816B1—EPO Interlocutory Decision dated Dec. 27, 2007.Applicant
• Opposition of EP1128816B1—Opponent Notice of Appeal dated Feb. 21, 2008.Applicant
• Opposition of EP1128816B1—Patentee Notice of Appeal dated Mar. 6, 2008.Applicant
• Opposition of EP1128816B1—Opponent Reasons for Appeal dated May 1, 2008.Applicant
• Opposition of EP 1128816B1—Experimental Report: cited as Document D23 in Opponent Appeal dated May 1, 2008.Applicant
• Opposition of EP1128816B1—Patentee Reasons for Appeal dated May 6, 2008.Applicant
• Opposition of EP1128816B1—Opponent Reply dated Nov. 5, 2008.Applicant
• Opposition of EP1128816B1—Patentee Reply dated Nov. 26, 2008.Applicant
• U.S. Appl. No. 09/419,114; (U.S. Patent No. 6,680,046) Office Action Dated Oct. 30, 2001.Applicant
• U.S. Appl. No. 09/419,114; (U.S. Patent No. 6,680,046) Office Action Dated Jul. 3, 2002.Applicant
• U.S. Appl. No. 09/419,114; (U.S. Patent No. 6,680,046) Notice of Allowability Dated Jul. 25, 2003.Applicant
• U.S. Appl. No. 10/692,785; (U.S. Publ. No. 2004/0091425) Office Action Dated Nov. 16, 2005.Applicant
• U.S. Appl. No. 10/692,785; (U.S. Publ. No. 2004/0091425) Office Action Dated Jun. 2, 2006.Applicant
• U.S. Appl. No. 10/692,785; (U.S. Publ. No. 2004/0091425) Office Action Dated Oct. 30, 2006.Applicant
• U.S. Appl. No. 10/692,785; (U.S. Publ. No. 2004/0091425) Interview Summary Dated Nov. 21, 2006.Applicant
• U.S. Appl. No. 10/692,785; (U.S. Publ. No. 2004/0091425) Office Action Dated Jul. 12, 2007.Applicant
• U.S. Appl. No. 10/692,785; (U.S. Publ. No. 2004/0091425) Office Action Dated Jan. 24, 2008.Applicant
• U.S. Appl. No. 10/692,785; (U.S. Publ. No. 2004/0091425) Office Action Dated Sep. 4, 2008.Applicant
• U.S. Appl. No. 10/692,785; (U.S. Publ. No. 2004/0091425) Notice of Allowability Dated Sep. 29, 2008.Applicant